Keywords: CEST / APT / NOE, Tumor
Motivation: Predicting glioma subtypes based on molecular profiles is crucial for treatment decisions and predicting survival rates.
Goal(s): We proposed a CEST-based deep learning method to predict IDH mutation and MGMT methylation status in glioma patients at the voxel level.
Approach: 86 patients were recruited for CEST experiments on 3T MRI scanner. A CEST-based deep learning method, composed of a 1D convolutional neural network, was proposed for different types of status prediction at the voxel level. The confusion matrix and ROC were conducted to evaluate the performance of the proposed method.
Results: Our method achieves higher accuracy compared to existing CEST-based prediction methods.
Impact: The proposed method may facilitate the application of CEST MRI in the diagnosis of glioma.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords